US ISS outlines the future of poison pills
IFLR is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

US ISS outlines the future of poison pills

Patrick McGurn, special counsel at Institutional Shareholder Services (ISS) discusses the role of shareholder rights plans in today’s age of shareholder activism

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
Gift this article